MOAT BIOTECHNOLOGY Corp filed a Form D with the Securities and Exchange Commission on 2025-10-20.
MOAT BIOTECHNOLOGY Corp filed a Form D notice of an exempt securities offering with the SEC on October 20, 2025. The filing reports $26K sold. Its industry group is Biotechnology. It names Scott Rollins (Executive Officer, Director, Promoter), Russell Rother (Executive Officer, Director, Promoter), Phillip Jones (Director) (SEC Form D, October 20, 2025).
Is this your company?
Sell to companies like MOAT BIOTECHNOLOGY Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns MOAT BIOTECHNOLOGY Corp.
Free to see. No signup.
More on the people and the money behind MOAT BIOTECHNOLOGY Corp, from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when MOAT BIOTECHNOLOGY Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when MOAT BIOTECHNOLOGY Corp raises, hires or launches. No email unless you switch it on.
Watch MOAT BIOTECHNOLOGY Corp →Get the full cited report on MOAT BIOTECHNOLOGY Corp
What the filing shows about MOAT BIOTECHNOLOGY Corp
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on MOAT BIOTECHNOLOGY Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives MOAT BIOTECHNOLOGY Corp's address as 5501 White Fences Road, Oklahoma City, OK 73131.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on MOAT BIOTECHNOLOGY Corp See pricing
MOAT BIOTECHNOLOGY Corp is a registered filer with the SEC (CIK 1944095) and has filed since 2022-10-11. 3 filings are on record, the latest on 2025-10-20.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
MOAT BIOTECHNOLOGY Corp's Form D of 2025-10-20 names Scott Rollins, Russell Rother, Phillip Jones and 3 more as its officers, directors or promoters.
Its new offerings report $128K sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Tetherex provides employees & certain services pursuant to that certain Administrative Services Agreement & that certain Research Services Agreement, both by & between Tetherex Pharmaceuticals Corporation & MOAT Biotechnology Corporation, dated 9/6/2022
Scott Rollins is named as Executive Officer and Director and Promoter on the Form D that MOAT BIOTECHNOLOGY Corp filed with the SEC on 20 October 2025, one of 5 people that filing names.
Russell Rother is named as Executive Officer and Director and Promoter on the Form D that MOAT BIOTECHNOLOGY Corp filed with the SEC on 20 October 2025, one of 5 people that filing names.
Phillip Jones is named as Director on the Form D that MOAT BIOTECHNOLOGY Corp filed with the SEC on 20 October 2025, one of 5 people that filing names.
Todd Foley is named as Director on the Form D that MOAT BIOTECHNOLOGY Corp filed with the SEC on 20 October 2025, one of 5 people that filing names.
Michael Moradi-Araghi is named as Director on the Form D that MOAT BIOTECHNOLOGY Corp filed with the SEC on 20 October 2025, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2025-10-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
| Entity | Stated role | Relationship on the filing | Where |
|---|---|---|---|
| Tetherex Pharmaceuticals Corporation | — | Promoter | Oklahoma City, OKLAHOMA |
What the filing shows about MOAT BIOTECHNOLOGY Corp
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on MOAT BIOTECHNOLOGY Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on MOAT BIOTECHNOLOGY Corp covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
These are companies, not individuals — the filing gives them no forename, or names them as a firm. They are listed apart so a firm is never read as a person.
No investor is drawn from a Form D — the form states how many invested and never who.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist MOAT BIOTECHNOLOGY CorpYou get an alert in MentionFox the next time this company shows up.
If you're behind MOAT BIOTECHNOLOGY Corp: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for MOAT BIOTECHNOLOGY Corp. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/moat-biotechnology-corp-form-d-25000001